Researchers at Weill Cornell Medicine and the Burke Neurological Institute have made an exciting discovery—a new drug that ...

Neuropathic pain is a chronic and debilitating condition that impacts around 10% of the population in both the United States and Europe. Despite advances in understanding the mechanisms of neuropathic ...

In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused ...

Conditions such as diabetes or nerve injury can cause neuropathic pain, which is often long lasting and has a major impact on quality of life. It is difficult to treat because the underlying factors ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

In this article, we explore treatment options for fibromyalgia, what current research can tell us about the disease and what ...

Deep pain at the back of the hip. Pain near the rear of your hip could be a sign of sciatica, a ligament injury, or one of ...

FREEHOLD, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced the ...

Cannabidiol (CBD) holds great promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Lower back pain is a common issue that affects around 8 out of 10 people at some point in their lives. Researchers are now ...

STOCKHOLM, SE / ACCESSWIRE / October 28, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases ...

Maria Kanellis is back home after she was re-admitted to the hospital following her adrenal gland surgery last week. She had ...